| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.902 | 0.001 | 0.902 | Angiotensin-converting enzyme inhibitor | 0.803 0.001 DBMET01139 | ||
| 0.871 | 0.002 | 0.871 | Diuretic | 0.526 0.006 DBMET01139 | ||
| 0.814 | 0.004 | 0.814 | Cardiotonic | 0.451 0.021 DBMET01139 | ||
| 0.775 | 0.003 | 0.775 | Vasodilator | 0.66 0.005 DBMET01139 | ||
| 0.617 | 0.024 | 0.617 | Analgesic | 0.248 0.185 DBMET01139 | ||
| 0.436 | 0.033 | 0.436 | Spasmolytic | 0.289 0.074 DBMET01139 | ||
| 0.414 | 0.023 | 0.414 | Hypolipemic | 0.373 0.03 DBMET01139 | ||
| 0.355 | 0.037 | 0.42 | Platelet antagonist | 0.42 0.024 DBMET01139 | DBMET01139 | |
| 0.384 | 0.07 | 0.428 | Immunosuppressant | 0.428 0.053 DBMET01139 | DBMET01139 | |
| 0.288 | 0.019 | 0.461 | Bone formation stimulant | 0.461 0.007 DBMET01139 | DBMET01139 | |
| 0.223 | 0.004 | 0.223 | Aminopeptidase microsomal inhibitor | 0.191 0.004 DBMET01139 | ||
| 0.248 | 0.029 | 0.248 | Cholinergic | 0.136 0.09 DBMET01139 | ||
| 0.204 | 0.004 | 0.204 | Aminopeptidase N inhibitor | 0.171 0.004 DBMET01139 | ||
| 0.232 | 0.039 | 0.298 | Thrombolytic | 0.298 0.024 DBMET01139 | DBMET01139 | |
| 0.276 | 0.086 | 0.316 | Immunostimulant | 0.316 0.074 DBMET01139 | DBMET01139 | |
| 0.189 | 0.003 | 0.189 | Neutral endopeptidase inhibitor | 0.086 0.005 DBMET01139 | ||
| 0.187 | 0.01 | 0.558 | Glutamate (mGluR) agonist | 0.558 0.003 DBMET01139 | DBMET01139 | |
| 0.191 | 0.036 | 0.191 | Acetylcholinesterase inhibitor | |||
| 0.153 | 0.004 | 0.153 | Squalene synthetase inhibitor | 0.144 0.004 DBMET01139 | ||
| 0.18 | 0.038 | 0.233 | Neurotrophic factor | 0.233 0.016 DBMET01139 | DBMET01139 | |
| 0.144 | 0.005 | 0.144 | Elastase inhibitor | |||
| 0.25 | 0.118 | 0.25 | Interleukin 2 agonist | 0.235 0.136 DBMET01139 | ||
| 0.123 | 0.006 | 0.321 | Prostaglandin F2 alpha antagonist | 0.321 0.003 DBMET01139 | DBMET01139 | |
| 0.089 | 0.003 | 0.089 | HMG CoA reductase inhibitor | 0.08 0.003 DBMET01139 | ||
| 0.218 | 0.158 | 0.218 | Apoptosis antagonist | |||
| 0.182 | 0.132 | 0.182 | Hypoglycemic | |||
| 0.069 | 0.021 | 0.191 | Endothelin-converting enzyme inhibitor | 0.191 0.005 DBMET01139 | DBMET01139 | |
| 0.053 | 0.007 | 0.07 | Glutamate (mGluR8) antagonist | 0.07 0.004 DBMET01139 | DBMET01139 | |
| 0.074 | 0.03 | 0.074 | Neuraminidase (influenza) inhibitor | |||
| 0.135 | 0.093 | 0.236 | Phospholipase A2 inhibitor | 0.236 0.027 DBMET01139 | DBMET01139 | |
| 0.093 | 0.052 | 0.443 | NMDA receptor antagonist | 0.443 0.004 DBMET01139 | DBMET01139 | |
| 0.081 | 0.041 | 0.203 | Aminopeptidase I inhibitor | 0.203 0.007 DBMET01139 | DBMET01139 | |
| 0.068 | 0.035 | 0.068 | Neuraminidase inhibitor | |||
| 0.053 | 0.021 | 0.053 | Leukocyte elastase inhibitor | |||
| 0.062 | 0.031 | 0.062 | Lipocortins synthesis agonist | |||
| 0.109 | 0.086 | 0.244 | Glutamate receptor antagonist | 0.244 0.016 DBMET01139 | DBMET01139 | |
| 0.128 | 0.11 | 0.128 | Growth hormone agonist | |||
| 0.022 | 0.007 | 0.097 | Angiotensin-converting enzyme 2 inhibitor | 0.097 0.003 DBMET01139 | DBMET01139 | |
| 0.146 | 0.134 | 0.545 | Anticonvulsant | 0.545 0.009 DBMET01139 | DBMET01139 | |
| 0.048 | 0.037 | 0.057 | Collagenase inhibitor | 0.057 0.02 DBMET01139 | DBMET01139 | |
| 0.087 | 0.077 | 0.087 | Protease inhibitor | |||
| 0.03 | 0.02 | 0.111 | AMPA 2 receptor antagonist | 0.111 0.005 DBMET01139 | DBMET01139 | |
| 0.017 | 0.009 | 0.282 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.282 0.003 DBMET01139 | DBMET01139 | |
| 0.045 | 0.043 | 0.068 | HCV NS3/NS4A protease inhibitor | 0.068 0.016 DBMET01139 | DBMET01139 | |
| 0.013 | 0.023 | 0.023 | Kainate receptor 3 antagonist | 0.023 0.008 DBMET01139 | DBMET01139 | |
| 0.029 | 0.04 | 0.039 | Growth factor receptor-bound protein 2 antagonist | 0.039 0.016 DBMET01139 | DBMET01139 | |
| 0.101 | 0.117 | 0.189 | Sphingosine 1-phosphate receptor 4 antagonist | 0.189 0.011 DBMET01139 | DBMET01139 | |
| 0.01 | 0.027 | 0.029 | Aminopeptidase A inhibitor | 0.029 0.006 DBMET01139 | DBMET01139 | |
| 0.012 | 0.03 | 0.035 | Kainate receptor 5 antagonist | 0.035 0.008 DBMET01139 | DBMET01139 | |
| 0.015 | 0.034 | 0.039 | Kainate receptor 4 antagonist | 0.039 0.01 DBMET01139 | DBMET01139 | |
| 0.022 | 0.042 | 0.039 | Leukotriene A4 hydrolase inhibitor | 0.039 0.025 DBMET01139 | DBMET01139 | |
| 0.026 | 0.047 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.018 DBMET01139 | DBMET01139 | |
| 0.024 | 0.05 | 0.538 | NMDA receptor subunit 3A antagonist | 0.538 0.002 DBMET01139 | DBMET01139 | |
| 0.126 | 0.165 | 0.199 | Phospholipase C inhibitor | 0.199 0.044 DBMET01139 | DBMET01139 | |
| 0.04 | 0.083 | 0.172 | Matrix metalloproteinase inhibitor | 0.172 0.011 DBMET01139 | DBMET01139 | |
| 0.11 | 0.157 | 0.208 | Sphingosine 1-phosphate receptor 5 antagonist | 0.208 0.008 DBMET01139 | DBMET01139 | |
| 0.024 | 0.073 | 0.065 | Membrane dipeptidase inhibitor | 0.065 0.009 DBMET01139 | DBMET01139 | |
| 0.074 | 0.131 | 0.11 | Cholesterol synthesis inhibitor | 0.11 0.075 DBMET01139 | DBMET01139 | |
| 0.029 | 0.091 | 0.062 | GABA B receptor antagonist | 0.062 0.011 DBMET01139 | DBMET01139 | |
| 0.031 | 0.096 | 0.049 | Prolyl endopeptidase inhibitor | 0.049 0.037 DBMET01139 | DBMET01139 | |
| 0.017 | 0.086 | 0.063 | Glutamate (mGluR group II) agonist | 0.063 0.011 DBMET01139 | DBMET01139 | |
| 0.021 | 0.092 | 0.041 | Glutamate (mGluR3) agonist | 0.041 0.009 DBMET01139 | DBMET01139 | |
| 0.031 | 0.106 | 0.103 | Matrix metalloproteinase (membrane-type) inhibitor | 0.103 0.014 DBMET01139 | DBMET01139 | |
| 0.029 | 0.105 | 0.1 | Glutamate (mGluR group III) antagonist | 0.1 0.005 DBMET01139 | DBMET01139 | |
| 0.052 | 0.13 | 0.154 | Aminopeptidase B inhibitor | 0.154 0.036 DBMET01139 | DBMET01139 | |
| 0.093 | 0.176 | 0.256 | Psychostimulant | 0.256 0.056 DBMET01139 | DBMET01139 | |
| 0.074 | 0.158 | 0.219 | M17 leucyl aminopeptidase inhibitor | 0.219 0.027 DBMET01139 | DBMET01139 | |
| 0.053 | 0.153 | 0.087 | GABA B receptor agonist | 0.087 0.03 DBMET01139 | DBMET01139 | |
| 0.034 | 0.134 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | 0.051 0.045 DBMET01139 | DBMET01139 | |
| 0.026 | 0.135 | 0.046 | Farnesyltransferase inhibitor | 0.046 0.032 DBMET01139 | DBMET01139 | |
| 0.004 | 0.113 | 0.037 | Kainate receptor 1 antagonist | 0.037 0.008 DBMET01139 | DBMET01139 | |
| 0.026 | 0.137 | 0.092 | Glutamate (mGluR4) antagonist | 0.092 0.006 DBMET01139 | DBMET01139 | |
| 0.028 | 0.141 | 0.084 | Sphingosine 1-phosphate receptor 3 antagonist | 0.084 0.015 DBMET01139 | DBMET01139 | |
| 0.162 | 0.28 | 0.287 | Antibacterial | 0.287 0.145 DBMET01139 | DBMET01139 | |
| 0.044 | 0.166 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.035 DBMET01139 | DBMET01139 | |
| 0.014 | 0.138 | 0.399 | NMDA 2A receptor antagonist | 0.399 0.003 DBMET01139 | DBMET01139 | |
| 0.01 | 0.134 | 0.101 | Kainate receptor antagonist | 0.101 0.007 DBMET01139 | DBMET01139 | |
| 0.037 | 0.164 | 0.182 | Metalloproteinase-2 inhibitor | 0.182 0.012 DBMET01139 | DBMET01139 | |
| 0.029 | 0.159 | 0.055 | Autotaxin inhibitor | 0.055 0.034 DBMET01139 | DBMET01139 | |
| 0.028 | 0.161 | 0.581 | Glutamate receptor agonist | 0.581 0.003 DBMET01139 | DBMET01139 | |
| 0.018 | 0.152 | 0.219 | NMDA receptor subunit 3B antagonist | 0.219 0.004 DBMET01139 | DBMET01139 | |
| 0.014 | 0.161 | 0.068 | Matrix metalloproteinase 1 inhibitor | 0.068 0.027 DBMET01139 | DBMET01139 | |
| 0.002 | 0.171 | 0.016 | Glutamate (mGluR6) agonist | 0.016 0.005 DBMET01139 | DBMET01139 | |
| 0.015 | 0.192 | 0.08 | Sphingosine 1-phosphate receptor agonist | 0.08 0.009 DBMET01139 | DBMET01139 | |
| 0.016 | 0.197 | 0.054 | AMPA 4 receptor antagonist | 0.054 0.013 DBMET01139 | DBMET01139 | |
| 0.006 | 0.203 | 0.045 | Kainate receptor 2 antagonist | 0.045 0.019 DBMET01139 | DBMET01139 | |
| 0.008 | 0.215 | 0.044 | Sphingosine 1-phosphate receptor 1 agonist | 0.044 0.026 DBMET01139 | DBMET01139 | |
| 0.023 | 0.252 | 0.077 | Sphingosine 1-phosphate receptor 1 antagonist | 0.077 0.015 DBMET01139 | DBMET01139 | |
| 0.067 | 0.3 | 0.165 | Sphingosine 1-phosphate receptor 2 antagonist | 0.165 0.025 DBMET01139 | DBMET01139 | |
| 0.01 | 0.244 | 0.213 | NMDA 2C receptor antagonist | 0.213 0.005 DBMET01139 | DBMET01139 | |
| 0.016 | 0.269 | 0.05 | Glutamate (mGluR8) agonist | 0.05 0.011 DBMET01139 | DBMET01139 | |
| 0.03 | 0.288 | 0.079 | Sphingosine 1-phosphate receptor antagonist | 0.079 0.048 DBMET01139 | DBMET01139 | |
| 0.005 | 0.275 | 0.038 | AMPA 3 receptor antagonist | 0.038 0.015 DBMET01139 | DBMET01139 | |
| 0.043 | 0.335 | 0.182 | Acetylcholine M1 receptor antagonist | 0.182 0.051 DBMET01139 | DBMET01139 | |
| 0.027 | 0.353 | 0.185 | GABA C receptor antagonist | 0.185 0.016 DBMET01139 | DBMET01139 | |
| 0.008 | 0.368 | 0.059 | Neutrophil collagenase inhibitor | 0.059 0.052 DBMET01139 | DBMET01139 | |
| 0.024 | 0.447 | 0.12 | GABA C receptor rho-1 antagonist | 0.12 0.04 DBMET01139 | DBMET01139 | |
| 0.012 | 0.438 | 0.164 | Glutamate (mGluR group III) agonist | 0.164 0.004 DBMET01139 | DBMET01139 | |
| 0.004 | 0.445 | 0.32 | NMDA 2 receptor antagonist | 0.32 0.005 DBMET01139 | DBMET01139 | |
| 0.006 | 0.535 | 0.037 | Glutamate (mGluR4) agonist | 0.037 0.018 DBMET01139 | DBMET01139 | |
| 0.029 | 0.562 | 0.11 | Glutamate (mGluR7) agonist | 0.11 0.042 DBMET01139 | DBMET01139 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |